Oren Lang-Furr, a Partner at Ernst & Young serving EY’s life sciences clients, will draw on his firm’s extensive evaluation of the new realities emerging in medtech, biotech and pharma and the major adjustments innovators need to make.
April 1, 2014: “Seismic Changes of Healthcare Necessitate New Approaches to Innovation: A National Perspective”
Paul Ramsey, MD, CEO of UW Medicine, will discuss the shift of healthcare toward Accountable Care Organizations, the dramatic changes of financial incentives and the consequent implications for innovations.
May 13, 2014: “Demonstrating Value in Health Innovation: Lessons from Comparative Effectiveness Research”
Larry Kessler, ScD, Chair of UW Deptment of Health Services and former Director, Center for Devices and Radiological Health, FDA, will consider the coming necessity for innovations to demonstrably provide value and how the experience with comparative effectiveness can help innovators gather the needed evidence.
Peter Neupert, Operating Partner of Health Evolution Partners and former VP of the Health Solutions Group at Microsoft will draw on his extensive experience with both institutional and consumer aspects of health IT to consider the enormous potential and serious pitfalls that make this area of innovation so challenging.